1. The 2017 update of the German clinical guideline on epidemiology, diagnostics, therapy, prevention, and management of uncomplicated urinary tract infections in adult patients: part 1;Kranz;Urol Int,2018
2. Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT);Wagenlehner;Expert Rev Pharmacoecon Outcomes Res,2018
3. Urinary tract infections: epidemiology, mechanisms of infection and treatment options;Flores-Mireles;Nat Rev Microbiol,2015
4. E. coli as an all-rounder: the thin line between commensalism and pathogenicity;Leimbach;Curr Top Microbiol Immunol,2013
5. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Uncomplicated urinary tract infections: developing drugs for treatment. Guidance for Industry. Silver Spring, MD: CDER; 2019. Available at:https://www.fda.gov/media/129531/download[accessed 8 February 2020].